Dynarrestin, a Novel Inhibitor of Cytoplasmic Dynein

GPCR Target: SMO

Authors: Susanne Höing, et al.

Company: Max Planck Institute for Molecular Biomedicine / Lead Discovery Center GmbH / Johns Hopkins University / Technische Universität Dortmund / University of Central Florida / University of Münster